Who owns FINCH THERAPEUTICS GROUP INC?
- Ticker: FNCH
- CUSIP Number: 31773d200
Tip: Access positions for across all investors
Analyze quarterly positions in Finch Therapeutics Group with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Finch Therapeutics Group stock
Who bought or sold FINCH THERAPEUTICS GROUP INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Baupost Group | 67k | $349k | 0% | Sep 2023 |
|
Susquehanna International | 59k | $301k | 0% | Sep 2023 |
|
Avenir Management Company | 46k | $237k | 100% | Sep 2023 |
|
Vanguard Group | 39k | $140k | 8% | Dec 2023 |
|
Lake Street Advisors Group | 21k | $222k | 0% | Sep 2023 |
|
Ikarian Capital | 6.9k | $25k | 0% | Dec 2023 |
|
Bleichroeder | 971.00 | $3.5k | 0% | Dec 2023 |
|
Tower Research Capital | 439.00 | $2.3k | -33% | Sep 2023 |
|
BlackRock | 341.00 | $1.8k | 0% | Sep 2023 |
|
Morgan Stanley | 123.00 | $637.004700 | 0% | Sep 2023 |
|
Royal Bank of Canada | 27.00 | $0 | 0% | Dec 2023 |
|
Bank of America Corporation | 12.00 | $42.999600 | 100% | Dec 2023 |
|
Wells Fargo & Company | 6.00 | $22.000200 | 0% | Dec 2023 |
|
Cutler | 3.00 | $0 | 0% | Dec 2023 |
|
Moisand Fitzgerald Tamayo | 3.00 | $11.000100 | 0% | Dec 2023 |
|
UBS Group | 2.00 | $7.000000 | 0% | Dec 2023 |
|
Who sold out of Finch Therapeutics Group?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
MSDC Management | Sep 2023 | 5.1k | $27k |
Ancora Advisors | Sep 2023 | 533.00 | $2.8k |
Steward Partners Investment Advisory | Sep 2023 | 75.00 | $389.002500 |